Submaximal Angioplasty for Severe Intracranial Atherosclerotic Stenosis: Benefit of Revascularization at Last

Umberto Pensato1,2, Andrew M Demchuk3, Geoffrey A Donnan4

  • 1Department of Neurology, IRCCS Humanitas Research Hospital, Milan, Italy (U.P.).

Stroke
|March 24, 2025
PubMed

Insights

Balloon angioplasty for symptomatic intracranial artery stenosis (BASIS) trial shows endovascular treatment benefits. Submaximal balloon angioplasty may offer a balance between safety and efficacy for stroke prevention.

Area of Science:

  • Neurology
  • Vascular Surgery
  • Interventional Cardiology

Background:

  • Intracranial atherosclerotic stenosis is a major cause of stroke, with high recurrence risk.
  • Previous trials of angioplasty and stenting for intracranial stenosis yielded negative or neutral results.
  • Coronary artery disease interventions inspired exploration of similar approaches for intracranial disease.

Purpose of the Study:

  • To evaluate the efficacy and safety of endovascular treatment for symptomatic intracranial atherosclerotic stenosis.
  • To determine if submaximal balloon angioplasty improves outcomes compared to previous approaches.

Main Methods:

  • The BASIS trial was a randomized trial investigating balloon angioplasty for symptomatic intracranial artery stenosis.
  • Focused on submaximal balloon angioplasty to balance early complications and long-term efficacy.

Main Results:

  • The BASIS trial demonstrated the benefits of endovascular treatment in this patient population.
  • Submaximal balloon angioplasty emerged as a potentially optimal technique.

Conclusions:

  • Endovascular treatment, specifically submaximal balloon angioplasty, shows promise for secondary stroke prevention in intracranial atherosclerotic stenosis.
  • Further research is needed to address remaining uncertainties before widespread clinical adoption.

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...